Medipharm Labs Expands Facility Threefold, Introduces New Automated Processes
Medipharm Labs (TSX: LABS) has received Health Canada licensing for its newly expanded production facility in Barrie, Ontario. The expanded
Read more
Medipharm Labs
MediPharm Labs Revenues Increase 37.8% to $43.38 Million
Medipharm Labs (TSX: LABS) announced third quarter earnings this morning, posting revenues of $43.38 million for the three month period
Read more
Medipharm Labs Applies for Nasdaq Listing
Medipharm Labs (TSX: LABS) announced this morning that it has submitted an application for listing on the Nasdaq stock exchange.
Read more
Medipharm Labs Appoints New Chief Financial Officer
Medipharm Labs (TSX: LABS) announced this morning that they have replaced their chief financial officer. Robert Kwon will now be
Read more
Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement
Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning, wherein Medipharm will supply a
Read more
Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement
Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their second manufacturing agreement of the
Read more
Medipharm Labs Reports Revenues of $31 million for Second Quarter
Medipharm Labs (TSX: LABS) filed its second quarter earnings after the bell this evening, reporting revenues of $31.47 million for
Read more